BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12609976)

  • 1. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells.
    Jirawatnotai S; Moons DS; Stocco CO; Franks R; Hales DB; Gibori G; Kiyokawa H
    J Biol Chem; 2003 May; 278(19):17021-7. PubMed ID: 12609976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.
    Bagui TK; Mohapatra S; Haura E; Pledger WJ
    Mol Cell Biol; 2003 Oct; 23(20):7285-90. PubMed ID: 14517297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
    Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
    Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
    Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y
    Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1.
    Robker RL; Richards JS
    Mol Endocrinol; 1998 Jul; 12(7):924-40. PubMed ID: 9658398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
    Jackson SK; DeLoose A; Gilbert KM
    J Immunol; 2001 Jan; 166(2):952-8. PubMed ID: 11145672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis.
    Martins CP; Berns A
    EMBO J; 2002 Jul; 21(14):3739-48. PubMed ID: 12110586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
    Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
    J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing roles for p21(waf1/cip1) and p27(kip1) in enterocyte differentiation, proliferation, and migration.
    Stehr W; Mercer TI; Bernal NP; Erwin CR; Warner BW
    Surgery; 2005 Aug; 138(2):187-94. PubMed ID: 16153426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1).
    Cheng T; Shen H; Rodrigues N; Stier S; Scadden DT
    Blood; 2001 Dec; 98(13):3643-9. PubMed ID: 11739168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa->luteal transition.
    Tong W; Kiyokawa H; Soos TJ; Park MS; Soares VC; Manova K; Pollard JW; Koff A
    Cell Growth Differ; 1998 Sep; 9(9):787-94. PubMed ID: 9751122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells.
    Muñoz-Alonso MJ; Acosta JC; Richard C; Delgado MD; Sedivy J; León J
    J Biol Chem; 2005 May; 280(18):18120-9. PubMed ID: 15746092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
    Bagui TK; Jackson RJ; Agrawal D; Pledger WJ
    Mol Cell Biol; 2000 Dec; 20(23):8748-57. PubMed ID: 11073976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
    Green SL; Freiberg RA; Giaccia AJ
    Mol Cell Biol; 2001 Feb; 21(4):1196-206. PubMed ID: 11158306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in p21(Cip1) and p27(Kip1) expression are not required for cell cycle entry and progression to S phase in Swiss 3T3 cells.
    Promwikorn W; Hawley SR; Pennington SR
    Cell Signal; 2000 Oct; 12(9-10):619-27. PubMed ID: 11080613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
    Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.